Optellum announces strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson, applying AI to transform early lung cancer treatment

IQ Capital (who invested in Optellum in 2019) is a deep-tech early stage VC investing in UK companies capable of dominating global markets.
IQ Capital